Ancient Plant Shows Promise Against Liver Cancer—What New Research Reveals

Researchers conducting a meta-analysis of animal studies have found compelling evidence that astragalus membranaceus, a traditional Chinese medicinal plant, may help fight hepatocellular carcinoma (HCC), the most common type of liver cancer. The analysis examined how the plant's main active ingredients work against liver cancer tumors, offering new insights into a potential treatment approach that could eventually complement conventional therapies.

What Is Hepatocellular Carcinoma and Why Does It Matter?

Hepatocellular carcinoma is a serious form of liver cancer that develops quietly—often without obvious symptoms in its early stages. By the time patients notice something is wrong, the disease has frequently progressed to advanced stages, making treatment more difficult. The global health burden is staggering: China alone accounts for 45.3% of worldwide HCC cases and 47.1% of deaths from the disease. Researchers project that cancer-related costs worldwide will reach approximately 25.2 trillion dollars between 2020 and 2050, with HCC accounting for about 6.5% of that total.

The disease typically develops from underlying liver damage caused by viral infections like hepatitis B and C, alcohol consumption, cirrhosis, or exposure to dietary contaminants such as aflatoxin. Because early-stage HCC can be treated with surgery while advanced cases require liver transplantation or immunotherapy, finding safer and more effective drug treatments remains a critical priority.

How Does Astragalus Membranaceus Work Against Liver Cancer?

Astragalus membranaceus, a legume plant used in traditional Chinese medicine for centuries, contains multiple active compounds with potential therapeutic properties. Researchers identified several key chemical components that appear to fight cancer cells through different mechanisms. The plant's main active ingredients include astragalus polysaccharides (APS) and astragaloside A (AS), compounds that have already shown anti-tumor activity against colorectal cancer, esophageal cancer, and ovarian cancer in previous studies.

The meta-analysis examined how these compounds work in animal models of liver cancer. The research revealed that astragalus membranaceus appears to fight HCC through multiple pathways:

• Tumor Reduction: The plant's active ingredients reduced both tumor weight and tumor volume in animal models, suggesting they may slow or inhibit cancer cell growth.
• Cell Cycle Arrest: The compounds stopped cancer cells from dividing and multiplying by interrupting their cell cycle, a critical mechanism for preventing tumor expansion.
• Apoptosis Promotion: Astragalus components triggered programmed cell death in cancer cells, essentially causing tumor cells to self-destruct rather than continue growing.
• Inflammatory Response Regulation: The plant helped regulate the body's inflammatory response, which plays a significant role in cancer development and progression.
• Liver Function Protection: Beyond fighting cancer, astragalus appeared to protect overall liver function, as measured by liver enzyme levels including alanine aminotransferase (ALT) and aspartate aminotransferase (AST).

At the molecular level, researchers found that astragalus works by regulating specific signaling pathways in cancer cells. The plant's active components inhibit the PI3K/AKT/mTOR signaling pathway, which is crucial for cancer cell survival and growth. They also regulate the pSmad3C/L and Nrf2/HO-1 signaling pathways, which control how cancer cells divide, migrate, and invade surrounding tissue.

What Do the Research Findings Actually Show?

The meta-analysis combined data from multiple animal studies to evaluate the effectiveness of astragalus membranaceus's main active ingredients against HCC. Researchers screened eight major scientific databases—including PubMed, Web of Science, Embase, and several Chinese medical literature databases—searching for all relevant animal studies published through July 2024.

The studies examined how different forms of astragalus treatment affected key markers of liver cancer and liver health. Primary outcomes measured included tumor weight, tumor volume, and liver enzyme levels (ALT and AST). Secondary outcomes included additional liver function markers like alkaline phosphatase (ALP) and immune system indicators including interleukin 2 (IL-2), interleukin 6 (IL-6), and interferon-gamma (IFN-gamma). The analysis included studies using total astragalus extract, astragaloside compounds, and astragalus polysaccharides at various dosages.

Steps to Understanding Astragalus as a Potential Liver Cancer Treatment

• Recognize the Research Stage: Current evidence comes from animal studies and laboratory experiments, not yet from human clinical trials, so astragalus should not be considered a proven treatment for liver cancer in people.
• Understand the Mechanisms: The plant works through multiple biological pathways simultaneously—reducing tumor growth, triggering cancer cell death, regulating inflammation, and protecting liver function—rather than through a single mechanism.
• Know the Active Compounds: The most promising components are astragalus polysaccharides and astragaloside A, which are the specific ingredients researchers believe drive the anti-cancer effects.
• Consider Future Clinical Development: Before astragalus can be recommended as a treatment, researchers must conduct human clinical trials to confirm safety and effectiveness in actual patients.

What Comes Next for This Research?

While the meta-analysis confirms that astragalus membranaceus shows significant promise in animal models of liver cancer, researchers emphasize that most studies to date involve laboratory and animal experiments. The therapeutic potential of astragalus for human patients with HCC awaits clarification through clinical trials.

The findings suggest that astragalus membranaceus could eventually become part of a comprehensive treatment strategy for hepatocellular carcinoma, potentially working alongside conventional therapies like surgery, immunotherapy, and liver transplantation. However, the path from promising animal research to approved human treatment typically requires years of additional study to establish safety, determine optimal dosages, and confirm effectiveness in real patients.

For people concerned about liver health or those with a family history of liver disease, this research underscores the importance of preventive measures—managing viral hepatitis risk, limiting alcohol consumption, and maintaining a healthy weight—while scientists continue investigating traditional plant compounds that may offer new therapeutic options in the future.